Mechanisms controlling production of membrane and secreted immunoglobulin during B cell development - PubMed (original) (raw)

Review

Mechanisms controlling production of membrane and secreted immunoglobulin during B cell development

Martha L Peterson. Immunol Res. 2007.

Abstract

The immunoglobulin gene which encodes both membrane-associated and secreted proteins through alternative RNA processing reactions has been a model system used for over 25 yr to better understand the regulatory mechanisms governing alternative RNA processing. This gene contains competing cleavage-polyadenylation and RNA splicing reactions and the relative use of the two pathways is differentially regulated between B cells and plasma cells. General cleavage-polyadenylation and RNA splicing reactions are both altered during B cell maturation to affect immunoglobulin expression. However, the specific factors involved in this regulation have yet to be identified clearly. As transcriptional regulators stimulate the developmental RNA processing switch, microarray analysis is a promising approach to identify candidate regulators of this complex RNA processing mechanism.

PubMed Disclaimer

Similar articles

• B-cell and plasma-cell splicing differences: a potential role in regulated immunoglobulin RNA processing.
  Bruce SR, Dingle RW, Peterson ML. Bruce SR, et al. RNA. 2003 Oct;9(10):1264-73. doi: 10.1261/rna.5820103. RNA. 2003. PMID: 13130140 Free PMC article.
• Immunoglobulin heavy chain gene regulation through polyadenylation and splicing competition.
  Peterson ML. Peterson ML. Wiley Interdiscip Rev RNA. 2011 Jan-Feb;2(1):92-105. doi: 10.1002/wrna.36. Wiley Interdiscip Rev RNA. 2011. PMID: 21956971 Review.
• A history of poly A sequences: from formation to factors to function.
  Edmonds M. Edmonds M. Prog Nucleic Acid Res Mol Biol. 2002;71:285-389. doi: 10.1016/s0079-6603(02)71046-5. Prog Nucleic Acid Res Mol Biol. 2002. PMID: 12102557 Review.

Cited by

• RNA polymerase II kinetics in polo polyadenylation signal selection.
  Pinto PA, Henriques T, Freitas MO, Martins T, Domingues RG, Wyrzykowska PS, Coelho PA, Carmo AM, Sunkel CE, Proudfoot NJ, Moreira A. Pinto PA, et al. EMBO J. 2011 May 20;30(12):2431-44. doi: 10.1038/emboj.2011.156. EMBO J. 2011. PMID: 21602789 Free PMC article.
• Phylogenetic analysis of mRNA polyadenylation sites reveals a role of transposable elements in evolution of the 3'-end of genes.
  Lee JY, Ji Z, Tian B. Lee JY, et al. Nucleic Acids Res. 2008 Oct;36(17):5581-90. doi: 10.1093/nar/gkn540. Epub 2008 Aug 30. Nucleic Acids Res. 2008. PMID: 18757892 Free PMC article.
• Genome edited B cells: a new frontier in immune cell therapies.
  Rogers GL, Cannon PM. Rogers GL, et al. Mol Ther. 2021 Nov 3;29(11):3192-3204. doi: 10.1016/j.ymthe.2021.09.019. Epub 2021 Sep 24. Mol Ther. 2021. PMID: 34563675 Free PMC article. Review.
• mRNA 3'end processing: A tale of the tail reaches the clinic.
  Hollerer I, Grund K, Hentze MW, Kulozik AE. Hollerer I, et al. EMBO Mol Med. 2014 Jan;6(1):16-26. doi: 10.1002/emmm.201303300. EMBO Mol Med. 2014. PMID: 24408965 Free PMC article. Review.
• Avidity in antibody effector functions and biotherapeutic drug design.
  Oostindie SC, Lazar GA, Schuurman J, Parren PWHI. Oostindie SC, et al. Nat Rev Drug Discov. 2022 Oct;21(10):715-735. doi: 10.1038/s41573-022-00501-8. Epub 2022 Jul 5. Nat Rev Drug Discov. 2022. PMID: 35790857 Free PMC article. Review.

References

1. 1. Mol Cell Biol. 2006 Sep;26(18):6762-71 - PubMed
2. 1. Mol Cell Biol. 2002 Jul;22(13):4771-80 - PubMed
3. 1. Genes Dev. 1995 Dec 1;9(23):3008-25 - PubMed
4. 1. Cell. 1979 Dec;18(4):1333-9 - PubMed
5. 1. Nature. 2001 Feb 15;409(6822):860-921 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program